Aegea Biotechnologies
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9955 Mesa Rim Rd, San Diego, California,...Phone Number
(619) 851-8923Website
www.aegeabiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Aegea Biotechnologies
Aegea Biotechnologies specializes in ultra-sensitive mutation detection using their patented Switch-Blocker technology, which efficiently suppresses normal DNA to amplify rare mutations. Their products are applicable in various fields including oncology, infectious disease testing, and personalized medicine, with uses in liquid biopsies, PCR diagnostics, and companion diagnostics. The company targets multi-national diagnostic firms and healthcare providers seeking advanced molecular diagnostic solutions. Aegea's technology enhances the sensitivity and specificity of assays, making them faster and more accurate for detecting clinically relevant genetic variants.Explore more
Aegea Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aegea Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aegea Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Aegea Biotechnologies launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aegea Biotechnologies has new funding data
Check out if Aegea Biotechnologies is spiking on competitors!
Click to see if Aegea Biotechnologies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aegea Biotechnologies
Check if Aegea Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aegea Biotechnologies recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Aegea Biotechnologies as Masked Content
Find more new buyers
Compare Similar Companies to Aegea Biotechnologies
Compare insights from companies similar to Aegea Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aegea Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aegea Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aegea Biotechnologies.
Aegea Biotechnologies Tech Stack
A closer look at the technologies used by Aegea Biotechnologies
Aegea Biotechnologies News & Media
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
SAN DIEGO--(BUSINESS WIRE)--Aegea Biotechnologies & Biocept enter supply agreement to validate and commercialize new COVID-19 test to help screen, manage, and evaluate patients.Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New COVID-19 (SARS-CoV-2) Tests
NEW YORK, NY and SAN DIEGO, CA, Nov. 18, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- As previously announced, during April 2020, Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop COVID-19 (novel coronavirus) assays. Aegea has made substantial progress in designing and developing two different, next generation assays for SARS-CoV-2.Aegea Biotechnologies, Inc. Announces the Award of Japanese Patent for Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Genetic Alterations and Variants
SAN DIEGO, Sept. 23, 2020 /PRNewswire/ -- Aegea Biotechnologies, Inc. (www.aegeabiotech.com, "Aegea"), a biotechnology company focusing on the development and commercialization of next generation nucleic acid and clinical diagnostic technologies, announces the award of Japanese Patent No....Aegea Biotechnologies, Inc. Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Aegea Biotechnologies, Inc. (www.aegeabiotech.com, "Aegea"), a biotechnology company focusing on the development and commercialization of next generation nucleic acid and clinical diagnostic technologies, announces that it has been selected as a...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aegea Biotechnologies
Sign Up For FreeTo access detailed company insights
Aegea Biotechnologies specializes in ultra-sensitive mutation detection using their patented Switch-Blocker technology, which efficiently suppresses normal DNA to amplify rare mutations. Their products are applicable in various fields including oncology, infectious disease testing, and personalized medicine, with uses in liquid biopsies, PCR diagno... Read More
